Amyloidosis
Trovati 3 articoli
- Cryopyrin-associated periodic syndromes: Rilonacept is first treatment
- The FDA ( Food and Drug Administration ) has approved a drug to help ease the suffering faced by those with certain chronic inflammatory diseases. Arcalyst ( Rilonacept, an Interleukin-1 blocker ) is now approved for the long term treatment of two cryopyrin-associated periodic syndromes ( CAPS )... (Leggi Articolo)
- Alzheimer's: calorie restriction may prevent disease
- A study, directed by Mount Sinai School of Medicine, suggests that experimental dietary regimens might calm or even reverse symptoms of Alzheimer's disease. The study, which is published in the Journal of Biological Chemistry, is the first to show that restricting caloric intake, specifically c... (Leggi Articolo)
- Chronic idiopathic axonal polyneuropathy: role of abnormal glucose metabolism
- Abnormal glucose metabolism, which occurs when the body has difficulty processing glucose into energy, is twice as common among patients with chronic nerve dysfunction of unknown cause than among the general population and may be a risk factor for the condition. Many older adults experience ne... (Leggi Articolo)
